WST West Pharmaceutical Services Earnings and EPS analysis

  1. Stocks
  2. Healthcare
  3. NYSE: WST
  4. Earnings
?
Relative Growth: Rel. Growth: 68
Relative Strength: Rel. Strength: 79
Relative Valuation: Rel. Valuation: 24
Relative Profitability: Rel. Profitability: 76

EPS in 2026 (TTM): $7.87

Last Report Period Date: Jun 30, 2026

As of August 2026, WST's current EPS stands at $7.87, according to the latest financial reports. West Pharmaceutical Services's EPS for 2025 amounted to $6.83, marking an increase from $6.75 in 2024. WST reported an EPS of $2.17 for the quarterly report ending on Jun 30, 2026.

WST earnings history

Historical annual and quarterly earnings per share (EPS) data for West Pharmaceutical Services
EPS (TTM)
$7.87
EPS Growth YoY (Quarterly)
19.2%
EPS (Quarterly)
$2.17
EPS Growth (Quarterly)
12.4%

For 2025, West Pharmaceutical Services's EPS was $6.83, an increase of 1.2% from $6.75 in 2024. The quarterly per-share earnings for the period ending Jun 30, 2026, was $2.17, indicating a 19.2% increase from the same quarter last year. WST's 12-month EPS stands at $7.87 as of June 2026. West Pharmaceutical Services's annual EPS in 2024 stood at $6.75, a 15.4% decrease year-over-year.

WST earnings chart

WST EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
19.2%
EPS growth YoY
1.2%
EPS growth 3Y avg
-4.6%
EPS growth 5Y avg
7.9%

West Pharmaceutical Services has registered an increase in EPS of 19.2% during the last 12 months (YoY, quarterly). In the last three years, WST recorded an average annual EPS growth rate of -4.6%. West Pharmaceutical Services had an average annual EPS growth rate of 7.9% during the last 5 years. Across the last decade, WST had an average annual EPS growth of 17.8%.

WST Earnings Waterfall

Breakdown of revenue, profit and net income for West Pharmaceutical Services

WST Earnings vs Peers

What are the earnings of WST compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
MDT Medtronic Plc 23.1 3.3% 9.8% 6.9%
JNJ Johnson & Johnson 29.15 90.6% 17.7% 14.8%
SYK Stryker Corp 35.06 8% 10.9% 14.8%
BDX Becton Dickinson & Company 42.93 -0.9% -0.6% 16.2%
WST West Pharmaceutical Services Inc 44.19 1.2% -4.6% 7.9%
ICUI ICU Medical Inc 92.64 100.6% N/A -62.7%
BAX Baxter International Inc N/A -47.2% N/A N/A
TFX Teleflex Incorporated N/A -1,462.4% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.